BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 16118353)

  • 1. Prostaglandins and cancer.
    Wang D; Dubois RN
    Gut; 2006 Jan; 55(1):115-22. PubMed ID: 16118353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
    Chell S; Kaidi A; Williams AC; Paraskeva C
    Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of prostaglandins in colon cancer].
    Myung SJ; Kim IH
    Korean J Gastroenterol; 2008 May; 51(5):274-9. PubMed ID: 18516010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects in NSAID-derived chemoprevention of colorectal cancer.
    Chell S; Patsos HA; Qualtrough D; H-Zadeh AM; Hicks DJ; Kaidi A; Witherden IR; Williams AC; Paraskeva C
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):667-71. PubMed ID: 16042570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in gene expression contribute to cancer prevention by COX inhibitors.
    Baek SJ; Eling TE
    Prog Lipid Res; 2006 Jan; 45(1):1-16. PubMed ID: 16337272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option?
    Jiménez P; García A; Santander S; Piazuelo E
    Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N; Levin B
    Curr Top Med Chem; 2005; 5(5):517-25. PubMed ID: 15974946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
    Doherty GA; Murray FE
    Expert Opin Ther Targets; 2009 Feb; 13(2):209-18. PubMed ID: 19236238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.
    Steele VE; Hawk ET; Viner JL; Lubet RA
    Mutat Res; 2003; 523-524():137-44. PubMed ID: 12628511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cyclooxygenase inhibitors in cancer prevention.
    Anderson WF; Umar A; Viner JL; Hawk ET
    Curr Pharm Des; 2002; 8(12):1035-62. PubMed ID: 11945150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
    Keller JJ; Giardiello FM
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs and chemoprevention.
    Rao CV; Reddy BS
    Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?
    Hull MA
    Eur J Cancer; 2005 Sep; 41(13):1854-63. PubMed ID: 16002278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
    Fajardo AM; Piazza GA
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N; Levin B
    Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma.
    Lin DW; Nelson PS
    Clin Prostate Cancer; 2003 Sep; 2(2):119-26. PubMed ID: 15040874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
    Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW
    J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
    Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
    Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.